Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Aris Liakos

Cardiovascular Risk Reduction in Type 2 Diabetes: Therapeutic Potential of Dapagliflozin

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy

Internal Medicine

English

Related publications

Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus

English

Type 2 Diabetes and Cardiovascular Risk Factors

Current Medical Research and Opinion

English

Cardiovascular Risk in Patients With Type 2 Diabetes

English

Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-Of-The-Art Review

Mayo Clinic Proceedings

English

Practice of Dapagliflozin Application in Patients With Type 2 Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY

English

Type 2 Diabetes and Cardiovascular Disease: Reducing the Risk

Journal of Managed Care Pharmacy

English

Dapagliflozin: A New Adjunct in the Treatment of Type 2 Diabetes Mellitus

International Journal of Basic & Clinical Pharmacology

English

Cardiovascular Risk Factors and Mitral Annular Calcification in Type 2 Diabetes

Atherosclerosis

Cardiovascular Medicine

English

Risk Reduction for Type 2 Diabetes in Aboriginal Children in Canada

Paediatrics and Child Health

English